Patents

US 9504716 B2: Methods of using adipose derived regenerative cells to promote restoration of intevertebral disc

Granted
2016-11-29
Filed
2010-08-09 application 12853110
Type
Utility · 17 claims
Elsewhere
Google Patents ↗ · USPTO patent document ↗ · USPTO Patent Center record ↗

Abstract

Regenerative cells present in adipose tissue are used to treat patients, including patients with musculoskeletal diseases or disorders. Methods of treating patients include processing adipose tissue to deliver a concentrated amount of regenerative cells obtained from the adipose tissue to a patient. The methods may be practiced in a closed system so that the stem cells are not exposed to an external environment prior to being administered to a patient. Accordingly, in a preferred method, regenerative cells present in adipose tissue are placed directly into a recipient along with such additives necessary to promote, engender or support a therapeutic musculoskeletal benefit.

Source: PVGPATDIS, file of 2026-04-10 (ipg161129.xml).

Assignees

AssigneeTypePlaceAlso on furp.orgSource
CYTORI THERAPEUTICS, INC. 21 patentsUS company or organizationSan Diego, CACYTORI THERAPEUTICS, INC. State business registration EXACT high confidence: identical full name and statePVGPATDIS, file of 2026-04-10

Inventors

InventorPlacePatentsPerson pageSource
Marc H. HedrickEncinitas, CA19PVGPATDIS, file of 2026-04-10
John K. FraserSan Diego, CA21PVGPATDIS, file of 2026-04-10
Susan Lynn RileySan Diego, CA5PVGPATDIS, file of 2026-04-10
Ronda Elizabeth SchreiberSan Diego, CA8PVGPATDIS, file of 2026-04-10

CPC categories

SubclassCategoryFirst groupSource
A61KPreparations for medical, dental or toiletry purposesA61K35/28PVGPATDIS, file of 2026-04-10
A61LMethods or apparatus for sterilising materials or objects in general; disinfection, sterilisation or deodorisation of air; chemical aspects of bandages, dressings, absorbent pads or surgical articles; materials for bandages, dressings, absorbent pads or surgical articlesA61L27/18PVGPATDIS, file of 2026-04-10
A61PSpecific therapeutic activity of chemical compounds or medicinal preparationsA61P19/02PVGPATDIS, file of 2026-04-10
C12NMicroorganisms or enzymes; compositions thereof; propagating, preserving, or maintaining microorganisms; mutation or genetic engineering; culture mediaC12N5/0667PVGPATDIS, file of 2026-04-10

Cooperative Patent Classification, as currently assigned (one row per subclass).

Assignments and security interests

RecordedWhatFromToReel/frameSource
2019-08-01Correction
Corrective assignment to correct the correct assignee's address previously recorded at reel: 049313 frame: 0434. assignor(s) hereby confirms the assignment.
CYTORI THERAPEUTICS, INC. signed 2019-04-24LOREM VASCULAR PTE. LTD. SINGAPORE49942/204ECORSEXC, file of 2026-09-25
2019-05-17Assignment
Assignment of assignor's interest
CYTORI THERAPEUTICS, INC. signed 2019-04-24LOREM VASCULAR PTE. LTD. MELBOURNE VIC49313/434ECORSEXC, file of 2026-09-25
2019-04-25Assignment
Assignment of assignor's interest
CYTORI THERAPEUTICS, INC. signed 2019-04-24LOREM VASCULAR PTE. LTD. SAN DIEGO, CA49651/1ECORSEXC, file of 2026-09-25
2019-04-25Release of security interest
Release of security interest
OXFORD FINANCE LLC signed 2019-04-23CYTORI THERAPEUTICS, INC. SAN DIEGO, CA49011/347ECORSEXC, file of 2026-09-25
2017-09-22Security interest Security interest
Security interest
CYTORI THERAPEUTICS, INC. signed 2017-09-20OXFORD FINANCE LLC, AS COLLATERAL AGENT ALEXANDRIA, VA43952/150ECORSEXC, file of 2026-09-25
2015-06-12Release of security interest
Release of security interest
OXFORD FINANCE LLC signed 2015-06-11CYTORI THERAPEUTICS, INC. SAN DIEGO, CA35902/191ECORSEXC, file of 2026-09-25
2013-07-03Release of security interest
Release of security interest
GENERAL ELECTRIC CAPITAL CORPORATION signed 2013-06-28CYTORI THERAPEUTICS, INC. SAN DIEGO, CA30734/778ECORSEXC, file of 2026-09-25
2013-06-28Security interest Security interest
Security agreement
CYTORI THERAPEUTICS, INC. signed 2013-06-28OXFORD FINANCE LLC ALEXANDRIA, VA30715/625ECORSEXC, file of 2026-09-25
2012-12-03Security interest Security interest
Security agreement
CYTORI THERAPEUTICS INC. signed 2010-06-11GENERAL ELECTRIC CAPITAL CORPORATION BETHESDA, MD29395/660ECORSEXC, file of 2026-09-25

Documents recorded with the USPTO Assignment Recordation Branch that list this patent. A security interest is a lender’s claim on the patent as collateral; a release ends it.

USPTO bulk data: PatentsView granted patents, disambiguated (PVGPATDIS) for patents, assignees, inventors, places and CPC categories; the USPTO Patent Assignment Dataset (ECORSEXC) for assignments and security interests. Patents filed in the last 20 years. No claims or full text. Links to other records are by name (and state): EXACT means the identical full name and state; FUZZY means a looser name match, with the confidence shown.